Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas

Additional prognostic and therapeutic biomarkers effective across different histological types of sarcoma are needed. Herein we evaluate expression of TAZ and YAP, the p53-MDM2 axis, and RABL6A, a novel oncoprotein with potential ties to both pathways, in sarcomas of different histological types. Im...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Chandni, Thomason, Jon, Kohlmeyer, Jordan L., Reisetter, Anna C., Ahirwar, Parmanand, Jahanseir, Khadijeh, Leidinger, Mariah, Ofori-Amanfo, Georgina, Fritchie, Karen, Velu, Sadanandan E., Breheny, Patrick, Quelle, Dawn E., Tanas, Munir R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057271/
https://www.ncbi.nlm.nih.gov/pubmed/33889298
http://dx.doi.org/10.18632/oncotarget.27928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057271/
https://www.ncbi.nlm.nih.gov/pubmed/33889298
http://dx.doi.org/10.18632/oncotarget.27928

Ejemplares similares